Kusakabe, Takato
Lin, Woan-Yu
Cheong, Jin-Gyu
Singh, Gagandeep http://orcid.org/0000-0003-3260-2631
Ravishankar, Arjun http://orcid.org/0000-0001-8366-4838
Yeung, Stephen T.
Mesko, Marissa
DeCelie, Meghan Bialt
Carriche, Guilhermina
Zhao, Zhen http://orcid.org/0000-0002-9742-5982
Rand, Sophie
Doron, Itai
Putzel, Gregory G.
Worgall, Stefan
Cushing, Melissa
Westblade, Lars
Inghirami, Giorgio http://orcid.org/0000-0001-5566-0864
Parkhurst, Christopher N.
Guo, Chun-Jun
Schotsaert, Michael http://orcid.org/0000-0003-3156-3132
GarcĂa-Sastre, Adolfo http://orcid.org/0000-0002-6551-1827
Josefowicz, Steven Z. http://orcid.org/0000-0001-7453-779X
Salvatore, Mirella http://orcid.org/0000-0002-8296-0376
Iliev, Iliyan D. http://orcid.org/0000-0003-0884-9749
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (DK113136)
U.S. Department of Health & Human Services | National Institutes of Health (DK121977)
U.S. Department of Health and Human Services (AI137157)
Article History
Received: 15 June 2023
Accepted: 6 September 2023
First Online: 23 October 2023
Competing interests
: The AGS Laboratory has received research support from GSK, Pfizer, Senhwa Biosciences, Kenall Manufacturing, Blade Therapeutics, Avimex, Johnson & Johnson, Dynavax, 7 Hills Pharma, Pharmamar, ImmunityBio, Accurius, Nanocomposix, Hexamer, N-fold LLC, Model Medicines, Atea Pharma, Applied Biological Laboratories and Merck, outside of the reported work. A.G.-S. has consulting agreements for the following companies involving cash and/or stock: Castlevax, Amovir, Vivaldi Biosciences, Contrafect, 7 Hills Pharma, Avimex, Pagoda, Accurius, Esperovax, Farmak, Applied Biological Laboratories, Pharmamar, CureLab Oncology, CureLab Veterinary, Synairgen, Paratus, Pfizer and Prosetta, outside of the reported work. A.G.-S. has been an invited speaker in meeting events organized by Seqirus, Janssen, Abbott and AstraZeneca; and is inventor on patents and patent applications on the use of antivirals and vaccines for the treatment and prevention of virus infections and cancer, owned by the Icahn School of Medicine at Mount Sinai, New York, outside of the reported work. M. Schotsaert has received unrelated research funding in sponsored research agreements from ArgenX BV, Moderna, 7 Hills Pharma and Phio Pharmaceuticals, which has no competing interest with this work. The other authors declare no competing interests related to this study.